Canadian reply to $500 million U.S. pharma suit: Guesses don’t make valid patents | Toronto Star

RT @DrRimmer: The Eli Lilly vs Canada dispute on drug patents highlights dangers of #ISDS for #CETA #TPP #TTIP http://t.co/urN2AKUgrj
#pate…

Source: www.thestar.com

Unknown's avatar

Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.

Posted in Uncategorized

Leave a comment